ERBB2 and breast carcinoma: ,18,19 Overexpression of HER-1 occurs in approximately 27%-30% of breast cancer cases, while overexpression of HER-2 is recorded in 20%-25% of the 1.5 million new breast cancer cases diagnosed annually worldwide.17